23andMe

23andMe special committee again rejects CEO Wojcicki’s take-private offer
CNBC
Tue, 03/4/25 - 09:57 am
23andMe
Anne Wojcicki
Medtech
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
CNBC
Mon, 02/24/25 - 04:58 pm
23andMe
Anne Wojcicki
Troubled 23andMe is exploring a sale of the business
Pharmaphorum
Wed, 01/29/25 - 11:12 am
23andMe
M&A
Medtech
diagnostics
What’s next for 23andMe?
Pharma Voice
Tue, 12/10/24 - 10:48 am
23andMe
Anne Wojcicki
genomics
23andMe, Mirador enter strategic research collaboration
Tip Ranks
Wed, 11/20/24 - 11:28 am
23andMe
Mirador
R&D
data
precision medicine
23andMe Cuts 40% of Its Workforce, Discontinues All Therapy Programs
US News and World Report
Mon, 11/11/24 - 06:36 pm
23andMe
Medtech
diagnostics
layoffs
23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows
Yahoo/Reuters
Tue, 10/1/24 - 10:56 am
23andMe
Anne Wojcicki
M&A
Medtech
diagnostics
23andMe independent directors quit board over unsatisfactory buyout plan from CEO
Yahoo/Reuters
Tue, 09/17/24 - 11:15 pm
23andMe
diagnostics
Anne Wojcicki
23andMe inches closes to cancer immunotherapy, guided by its genetic database
Pharma Voice
Tue, 08/20/24 - 10:28 am
23andMe
diagnostics
Medtech
cancer immunotherapy
drug discovery
23andMe CEO Anne Wojcicki files proposal to take company private as stock craters
CNBC
Fri, 08/2/24 - 11:29 am
23andMe
Medtech
diagnostics
Anne Wojcicki
Why 23andMe Stock Tumbled 10% on Tuesday
Motley Fool
Tue, 06/4/24 - 11:35 pm
23andMe
diagnostics
colorectal cancer
23andMe Jumps as CEO Floats Taking DNA Tester Private
Yahoo/Bloomberg
Thu, 04/18/24 - 11:17 am
23andMe
diagnostics
Anne Wojcicki
23andMe confirms hackers stole ancestry data on 6.9 million users
TechCrunch
Mon, 12/4/23 - 06:01 pm
23andMe
cybersecurity
hackers
CEO Anne Wojcicki on turning 23andMe into a ‘full-fledged biotech’
BioPharma Dive
Wed, 11/8/23 - 10:20 am
23andMe
biotech
Anne Wojcicki
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
Drugs.com
Tue, 09/5/23 - 11:15 am
23andMe
BRCA
diagnostics
FDA
Why 23andMe Holding Stock Plummeted by 13% Today
Motley Fool
Wed, 08/9/23 - 10:00 pm
earnings
23andMe
diagnostics
genetics
23andMe doses first patient in ph2a anti-tumour monotherapy
Pharmaphorum
Wed, 03/1/23 - 09:48 am
23andMe
clinical trials
solid tumors
23ME-00610
23andMe CEO Anne Wojcicki on Bringing Health Information Directly to People
Motley Fool
Sat, 04/30/22 - 02:36 pm
23andMe
Medtech
diagnostics
Anne Wojcicki
consumers
The top 10 medtech M&A deals of 2021
Fierce Biotech
Tue, 01/18/22 - 10:35 am
devices
Medtech
M&A
Thermofisher
PPD
23andMe
PerkinElmer
BioLegend
Illumina
Grail
Baxter International
Hill-Rom
Steris
Cantel Medical
Siemens Healthineers
Varian Medical Systems
23andMe Keeps Snagging FDA Nods for Cancer Marker Tests
Medical Devices and Diagnostics Industry
Tue, 01/11/22 - 10:15 pm
23andMe
FDA
diagnostics
prostate cancer
cancer

Pages